Veridix Data Management Agent
The Veridix Data Management Agent empowers data management teams to work faster, more effectively, and more consistently across studies. By automating repetitive tasks - such as discrepancy detection, query review, and data status tracking - the agent enables earlier issue detection and resolution, reduces manual burden, and improves coordination with clinical, safety, and programming teams. Scalable and configurable by study, it drives speed and quality at every trial milestone.
New Mountain Capital Announces Growth Partnership with Emmes
New Mountain Capital Announces Growth Partnership with Emmes
Partnership to Support Emmes’ Next Phase of Tech-Enabled Growth
Download Go back to Newsroom
Partnership to Support Emmes’ Next Phase of Tech-Enabled Growth
Emmes Introduces Telehealth Capabilities into Advantage eClinical
Emmes Introduces Telehealth Capabilities into Advantage eClinical
The latest upgrade is part of wider goals to create the industry’s first unified digital data platform for decentralized and hybrid trials
Download Go back to Newsroom
The latest upgrade is part of wider goals to create the industry’s first unified digital data platform for decentralized and hybrid trials
Emmes Appoints Peter Ronco as Chief Executive Officer
Emmes Appoints Peter Ronco as Chief Executive Officer
Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement
Rockville, MD, September 20, 2023 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.
Download Go back to Newsroom
Ronco’s Global Pharmaceutical Experience Will Support the Next Chapter of Emmes’ Growth and Technology Enablement
Rockville, MD, September 20, 2023 – Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Peter Ronco has been named Chief Executive Officer, effective immediately.
Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies
Emmes Applauded by Frost & Sullivan for Streamlining Clinical Trials and for Its Competitive Strategies
Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development.
Download Go back to Newsroom
Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development.
Emmes Acquires Essex Management
Emmes Acquires Essex Management
A Technology Catalyst Enabling Innovative Clinical Research, Essex Enriches and Complements Emmes’ Services
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of Essex Management. Essex offers bioinformatics and health information technology (HIT) consulting services to government, private sector and academic organizations.
Download Go back to Newsroom
A Technology Catalyst Enabling Innovative Clinical Research, Essex Enriches and Complements Emmes’ Services
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the acquisition of Essex Management. Essex offers bioinformatics and health information technology (HIT) consulting services to government, private sector and academic organizations.
Emmes Opens New Office in Wilmington, North Carolina
Emmes Opens New Office in Wilmington, North Carolina
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the opening of a new office in Wilmington, North Carolina.
According to Emmes Chief Executive Officer Dr. Christine Dingivan, “Wilmington is a center for clinical research innovation, and creating this new office will encourage even more collaboration and idea-sharing among our employees in the area. We are thrilled to expand our presence in a community viewed as an incubator for the CRO industry.”
Download Go back to Newsroom
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced the opening of a new office in Wilmington, North Carolina.
According to Emmes Chief Executive Officer Dr. Christine Dingivan, “Wilmington is a center for clinical research innovation, and creating this new office will encourage even more collaboration and idea-sharing among our employees in the area. We are thrilled to expand our presence in a community viewed as an incubator for the CRO industry.”
Matt Honan Joins Emmes as Vice President and Head of Corporate Development
Matt Honan Joins Emmes as Vice President and Head of Corporate Development
Mergers & Acquisitions (M&A) Expertise Adds Value to Emmes’ Growth Plans
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Honan has joined the company as vice president and global head of corporate development.
Download Go back to Newsroom
Mergers & Acquisitions (M&A) Expertise Adds Value to Emmes’ Growth Plans
Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Matt Honan has joined the company as vice president and global head of corporate development.